Trials / Completed
CompletedNCT00035061
A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with bladder cancer will be participating in this study for the treatment of abnormal cells in the bladder that have returned after initial treatment OR have moved to a new site in the body.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pemetrexed |
Timeline
- First posted
- 2002-05-03
- Last updated
- 2006-07-19
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00035061. Inclusion in this directory is not an endorsement.